Monika Janda1, Philippa Youl2, Rachel Neale3, Joanne Aitken4, David Whiteman3, Louisa Gordon5, Peter Baade6. 1. School of Public Health and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. 2. Queensland Cancer Council, Brisbane, Queensland, Australia. 3. Queensland Institute of Medical Research, Brisbane, Queensland, Australia. 4. School of Public Health and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia2Queensland Cancer Council, Brisbane, Queensland, Australia. 5. Griffith University, Brisbane, Queensland, Australia. 6. School of Public Health and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia2Queensland Cancer Council, Brisbane, Queensland, Australia4Griffith University, Brisbane, Queensland, Australia.
Abstract
IMPORTANCE: Older men are at risk of dying of melanoma. OBJECTIVE: To assess attendance at and clinical outcomes of clinical skin examinations (CSEs) in older men exposed to a video-based behavioral intervention. DESIGN, SETTING, AND PARTICIPANTS: This was a behavioral randomized clinical trial of a video-based intervention in men aged at least 50 years. Between June 1 and August 31, 2008, men were recruited, completed baseline telephone interviews, and were than randomized to receive either a video-based intervention (n = 469) or brochures only (n = 461; overall response rate, 37.1%) and were again interviewed 7 months later (n = 870; 93.5% retention). INTERVENTIONS: Video on skin self-examination and skin awareness and written informational materials. The control group received written materials only. MAIN OUTCOMES AND MEASURES: Participants who reported a CSE were asked for the type of CSE (skin spot, partial body, or whole body), who initiated it, whether the physician noted any suspicious lesions, and, if so, how lesions were managed. Physicians completed a case report form that included the type of CSE, who initiated it, the number of suspicious lesions detected, how lesions were managed (excision, nonsurgical treatment, monitoring, or referral), and pathology reports after lesion excision or biopsy. RESULTS: Overall, 540 of 870 men (62.1%) self-reported a CSE since receiving intervention materials, and 321 of 540 (59.4%) consented for their physician to provide medical information (received for 266 of 321 [82.9%]). Attendance of any CSE was similar between groups (intervention group, 246 of 436 [56.4%]; control group, 229 of 434 [52.8%]), but men in the intervention group were more likely to self-report a whole-body CSE (154 of 436 [35.3%] vs 118 of 434 [27.2%] for control group; P = .01). Two melanomas, 29 squamous cell carcinomas, and 38 basal cell carcinomas were diagnosed, with a higher proportion of malignant lesions in the intervention group (60.0% vs 40.0% for controls; P = .03). Baseline attitudes, behaviors, and skin cancer history were associated with higher odds of CSE and skin cancer diagnosis. CONCLUSIONS AND RELEVANCE: A video-based intervention may increase whole-body CSE and skin cancer diagnosis in older men. TRIAL REGISTRATION: anzctr.org.au Identifier: ACTRN12608000384358.
RCT Entities:
IMPORTANCE: Older men are at risk of dying of melanoma. OBJECTIVE: To assess attendance at and clinical outcomes of clinical skin examinations (CSEs) in older men exposed to a video-based behavioral intervention. DESIGN, SETTING, AND PARTICIPANTS: This was a behavioral randomized clinical trial of a video-based intervention in men aged at least 50 years. Between June 1 and August 31, 2008, men were recruited, completed baseline telephone interviews, and were than randomized to receive either a video-based intervention (n = 469) or brochures only (n = 461; overall response rate, 37.1%) and were again interviewed 7 months later (n = 870; 93.5% retention). INTERVENTIONS: Video on skin self-examination and skin awareness and written informational materials. The control group received written materials only. MAIN OUTCOMES AND MEASURES: Participants who reported a CSE were asked for the type of CSE (skin spot, partial body, or whole body), who initiated it, whether the physician noted any suspicious lesions, and, if so, how lesions were managed. Physicians completed a case report form that included the type of CSE, who initiated it, the number of suspicious lesions detected, how lesions were managed (excision, nonsurgical treatment, monitoring, or referral), and pathology reports after lesion excision or biopsy. RESULTS: Overall, 540 of 870 men (62.1%) self-reported a CSE since receiving intervention materials, and 321 of 540 (59.4%) consented for their physician to provide medical information (received for 266 of 321 [82.9%]). Attendance of any CSE was similar between groups (intervention group, 246 of 436 [56.4%]; control group, 229 of 434 [52.8%]), but men in the intervention group were more likely to self-report a whole-body CSE (154 of 436 [35.3%] vs 118 of 434 [27.2%] for control group; P = .01). Two melanomas, 29 squamous cell carcinomas, and 38 basal cell carcinomas were diagnosed, with a higher proportion of malignant lesions in the intervention group (60.0% vs 40.0% for controls; P = .03). Baseline attitudes, behaviors, and skin cancer history were associated with higher odds of CSE and skin cancer diagnosis. CONCLUSIONS AND RELEVANCE: A video-based intervention may increase whole-body CSE and skin cancer diagnosis in older men. TRIAL REGISTRATION: anzctr.org.au Identifier: ACTRN12608000384358.
Authors: Alan C Geller; Barbra A Dickerman; Jennifer M Taber; Laura A Dwyer; Anne M Hartman; Frank M Perna Journal: Prev Med Date: 2018-02-06 Impact factor: 4.018
Authors: Elizabeth J Klein; Maria Karim; Kumar Sukhdeo; Katerina Svigos; Lu Yin; Erik Peterson; Daniel Gutierrez; Jerry Shapiro; Kristen Lo Sicco Journal: JAAD Int Date: 2022-09-07
Authors: Deonna M Ackermann; Mbathio Dieng; Ellie Medcalf; Marisa C Jenkins; Cathelijne H van Kemenade; Monika Janda; Robin M Turner; Anne E Cust; Rachael L Morton; Les Irwig; Pascale Guitera; H Peter Soyer; Victoria Mar; Jolyn K Hersch; Donald Low; Cynthia Low; Robyn P M Saw; Richard A Scolyer; Dorothy Drabarek; David Espinoza; Anthony Azzi; Alister M Lilleyman; Amelia K Smit; Peter Murchie; John F Thompson; Katy J L Bell Journal: JAMA Dermatol Date: 2022-01-01 Impact factor: 11.816
Authors: Nadine A Kasparian; Shab Mireskandari; Phyllis N Butow; Mbathio Dieng; Anne E Cust; Bettina Meiser; Kristine Barlow-Stewart; Scott Menzies; Graham J Mann Journal: Support Care Cancer Date: 2016-07-27 Impact factor: 3.603
Authors: Louisa Gordon; Catherine Olsen; David C Whiteman; Thomas M Elliott; Monika Janda; Adele Green Journal: BMJ Open Date: 2020-02-26 Impact factor: 2.692
Authors: Deonna M Ackermann; Amelia K Smit; Monika Janda; Cathelijne H van Kemenade; Mbathio Dieng; Rachael L Morton; Robin M Turner; Anne E Cust; Les Irwig; Jolyn K Hersch; Pascale Guitera; H Peter Soyer; Victoria Mar; Robyn P M Saw; Donald Low; Cynthia Low; Dorothy Drabarek; David Espinoza; Jon Emery; Peter Murchie; John F Thompson; Richard A Scolyer; Anthony Azzi; Alister Lilleyman; Katy J L Bell Journal: Trials Date: 2021-05-04 Impact factor: 2.279
Authors: Peter Murchie; Julia L Allan; William Brant; Matthew Dennis; Susan Hall; Judith Masthoff; Fiona M Walter; Marie Johnston Journal: BMJ Open Date: 2015-08-06 Impact factor: 2.692